2022 - Ifm_05-may

If you are looking for guidance based on this study's results:

One critical finding was an increased risk of developing a second primary malignancy (SPM) while on long-term lenalidomide maintenance. Patient Considerations IFM_05-May 2022

The study demonstrated a clear overall survival benefit for patients receiving maintenance therapy compared to a placebo. If you are looking for guidance based on